- Home
- FDMT vs LDI Comparison
FDMT vs LDI Comparison
Compare FDMT & LDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- LDI
- Stock Information
- Founded
- FDMT 2013
- LDI 2010
- Country
- FDMT United States
- LDI United States
- Employees
- FDMT N/A
- LDI N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- LDI Finance: Consumer Services
- Sector
- FDMT Health Care
- LDI Finance
- Exchange
- FDMT Nasdaq
- LDI Nasdaq
- Market Cap
- FDMT 192.2M
- LDI 221.2M
- IPO Year
- FDMT 2020
- LDI 2021
- Fundamental
- Price
- FDMT $6.61
- LDI $2.28
- Analyst Decision
- FDMT Buy
- LDI Sell
- Analyst Count
- FDMT 9
- LDI 3
- Target Price
- FDMT $30.63
- LDI $2.30
- AVG Volume (30 Days)
- FDMT 733.0K
- LDI 2.5M
- Earning Date
- FDMT 08-11-2025
- LDI 11-04-2025
- Dividend Yield
- FDMT N/A
- LDI N/A
- EPS Growth
- FDMT N/A
- LDI N/A
- EPS
- FDMT N/A
- LDI N/A
- Revenue
- FDMT $33,000.00
- LDI $1,124,074,000.00
- Revenue This Year
- FDMT $9,921.62
- LDI $21.95
- Revenue Next Year
- FDMT N/A
- LDI $15.72
- P/E Ratio
- FDMT N/A
- LDI N/A
- Revenue Growth
- FDMT N/A
- LDI 27.06
- 52 Week Low
- FDMT $2.24
- LDI $1.01
- 52 Week High
- FDMT $17.41
- LDI $3.23
- Technical
- Relative Strength Index (RSI)
- FDMT 57.82
- LDI 65.35
- Support Level
- FDMT $5.97
- LDI $1.81
- Resistance Level
- FDMT $7.33
- LDI $2.16
- Average True Range (ATR)
- FDMT 0.48
- LDI 0.15
- MACD
- FDMT -0.11
- LDI 0.01
- Stochastic Oscillator
- FDMT 39.51
- LDI 98.94
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.